Patents Represented by Attorney Genga & Associates P.C.
  • Patent number: 8012958
    Abstract: The present invention relates to methods of and compositions for treating and relieving symptoms and disease associated with indications caused by a physiological drive to alleviate a sensation of anxiety. In one treatment method, methods of, and compositions for, modulating the expression of certain GABAA receptor subunits are used to treat anxiety-related disorders and depressive disorders associated with physiological tolerance to endogenous neurosteroids.
    Type: Grant
    Filed: April 7, 2006
    Date of Patent: September 6, 2011
    Assignee: Hythlam, Inc.
    Inventors: Sanjay Sabnani, Donald Wesson